S.M.A.I.O Past Earnings Performance
Past criteria checks 3/6
There is insufficient data on S.M.A.I.O's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 14.3% |
Return on equity | 31.5% |
Net Margin | 120.5% |
Next Earnings Update | 18 Oct 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How S.M.A.I.O makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 22 | 3 | 4 | 3 | 0 |
31 Mar 22 | 3 | 0 | 3 | 0 |
31 Dec 21 | 3 | -3 | 3 | 0 |
30 Sep 21 | 3 | -3 | 3 | 0 |
30 Jun 21 | 3 | -3 | 3 | 0 |
31 Mar 21 | 2 | -2 | 2 | 0 |
31 Dec 20 | 2 | -2 | 2 | 0 |
31 Dec 19 | 1 | -2 | 2 | 0 |
Quality Earnings: G3O has a large one-off gain of €7.4M impacting its last 12 months of financial results to 30th June, 2022.
Growing Profit Margin: G3O became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: G3O has become profitable over the past 5 years.
Accelerating Growth: G3O has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: G3O has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: G3O's Return on Equity (31.5%) is considered high.